Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
2.020
+0.360 (21.69%)
At close: Aug 13, 2025, 4:00 PM
1.970
-0.050 (-2.47%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $255.81 million as of August 13, 2025. Its market cap has increased by 286.36% in one year.
Market Cap
255.81M
Enterprise Value
55.25M
1-Year Change
286.36%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $255.81M, a decrease of -80.31%. That is a compound annual growth rate of -30.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 255.81M | 85.04% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |